In contrast to solid cancers, which often require genetic modifications and complex cellular
reprogramming for effective metastatic dissemination, leukaemic cells uniquely possess the …

CD24 is a highly glycosylated protein with a small protein core that is linked to the plasma
membrane via a glycosyl‐phosphatidylinositol anchor. CD24 is primarily expressed by …

Cluster of differentiation 24 (CD24) is a small, highly glycosylated cell adhesion protein that
is normally expressed by immune as well as epithelial, neural, and muscle cells. Tumor …

Breast cancer metastatic relapse can occur years after therapy, indicating that disseminated
breast cancer cells (BCCs) have a prolonged dormant phase before becoming proliferative …

In industrialized countries, cancer is the second leading cause of death after cardiovascular
disease. Most cancer patients die because of metastases, which consist of the self …

Multivalent binding, the simultaneous binding of multiple ligands to multiple receptors, has
played a central role in a number of pathological processes, including the attachment of …

CD24 and its ligand Siglec-10 were described as an innate immune checkpoint in
carcinoma. Here, we investigated this axis in B-cell lymphoma by assessing CD24 …

Glioma is a malignant tumor with the highest incidence among all brain tumors (about 46%
of intracranial tumors) and is the most common primary intracranial tumor. Among them …

Cancer is the second cause of mortality worldwide, primarily owing to failure to cure
metastatic disease. The need to target the metastatic process to reduce mortality is clear and …

Central nervous system metastases have been reported in 15–25% of breast cancer
patients, and the incidence is increasing. Moreover, the survival of these patients is …